ADAT technology (GEMMA)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameADAT technology (GEMMA)
Drug Alias NameActivation Dependent Apoptosis Technology (GEMMA)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunosuppressantsApoptosis modulators
TargetsUpdating
Therapy Area/IndicationsInflammationHypersensitivityAutoimmune Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGEMMA Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGEMMA Biotechnology
Active IndicationsN/A
Inactive IndicationsInflammationHypersensitivityAutoimmune Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A